We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Phosphate Group Is Key Regulator of Melatonin Metabolism

By Biotechdaily staff writers
Posted on 05 Nov 2003
Researchers studying the sleep-inducing hormone melatonin have developed a method to modify the enzyme responsible for the synthesis of melatonin in order to prevent its degradation.

To study melatonin metabolism in cells, investigators at Johns Hopkins University (Baltimore, MD, USA) modified serotonin N-acetyltransferase (arylalkylamine N-acetyltransferase, AANAT) through the incorporation of a nonhydrolyzable phosphoserine/threonine mimetic, phosphonomethylenealanine (Pma), at position 31 (AANAT-Pma31). The presence of the added chemical group prevented enzymes that normally inactivate AANAT from removing the phosphate at position 31. The presence of the mimetic also improved the enzyme's ability to bind to a protein known as 14-3-3, further increasing the enzyme's stability and delaying its degradation. These findings were published October 26, 2003, in the online edition of Nature Structural Biology.

"We have discovered that addition and removal of the phosphate group at this position is the key step in regulating the enzyme's stability,” explained senior author Dr. Philip Cole, professor of pharmacology and molecular sciences at Johns Hopkins University. "When this phosphate group is present, the enzyme is stable.”




Related Links:
Johns Hopkins University

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
05 Nov 2003  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
05 Nov 2003  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
05 Nov 2003  |   BioResearch